Co Founder and CEO

Sr. Vice President Finance and Administration

Surgical oncology specialist Onkos raises $17.6M series B to build marketing efforts

Onkos Surgical® Opens New Innovation Center for NanoCept® Antibacterial Technology

Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology

Healthcare Expansion Increases Anti-Microbial Coatings Market: Forecast to grow with 9.8% CAGR Through 2035

0.3333333432674408

Field Product Director

ONKOS Surgical is dedicated to providing innovative solutions for surgical oncology patients. The Field Product Director is responsible for driving product adoption and utilization by collaborating with surgeons and commercial leadership to ensure high-quality clinical support and training.

Field Product Director - Great Lakes Region

Chief Executive Officer

Scholar Rock Highlights 2026 Strategic Priorities

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site

FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults

0.6666666865348816

Associate Director, Field Reimbursement

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. The Associate Director, Field Reimbursement will support patients and caregivers by enhancing access to a potentially novel treatment option for individuals living with Spinal Muscular Atrophy (SMA) through strategic account management and education.

Associate Director, Field Reimbursement (Great Lakes)

VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Associate Director, Thought Leader Liaison - Neuroscience

Johnson & Johnson Innovative Medicine is focused on healthcare innovation, aiming to build a world where complex diseases are effectively managed. The Associate Director, Thought Leader Liaison - Neuroscience will lead KOL engagement strategies in the Great Lakes region, collaborating with various stakeholders to enhance brand advocacy and drive educational initiatives.

Associate Director, Thought Leader Liaison - Neuroscience - Great Lakes

Chief Sustainability Officer

Strategic Advisor

MHRA approves Kostaive mRNA COVID-19 vaccine

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

CSL just upgraded at Canaccord, here's why

Aussie giant takes $17b hit as more Americans shun vaccines

Associate Director, Field Reimbursement Manager Resourcing

CSL Behring is a global biotherapeutics leader committed to saving lives through innovative therapies. The Associate Director, Field Reimbursement Manager Resourcing will develop and implement resources to support healthcare professional and patient access to CSL products, collaborating across functions to meet customer needs and advance market access strategies.

President & Chief Executive Officer

EVP & Chief Commercial Officer

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

Harmony Biosciences Guides to Over $1 Billion in WAKIX® R...

Harmony Biosciences projects flagship drug will hit $1B; ends work on another product

Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Field Reimbursement Manager - Great Lakes

Harmony Biosciences is a pharmaceutical company focused on providing novel treatment options for individuals with rare neurological disorders. They are seeking a Field Reimbursement Manager to support the reimbursement process for providers and patients, educate healthcare providers, and manage access to Harmony’s products within the Great Lakes territory.

President, Oncology

Associate Director, Statistical Programming

CORT INVESTIGATION: Corcept Therapeutics Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Corcept Therapeutics Incorporated (CORT)

INVESTOR ALERT: Investigation of Corcept Therapeutics Incorporated (CORT) by Holzer & Holzer, LLC

Associate Director, Field Reimbursement Lead

Corcept Therapeutics is leading the way in the research and development of cortisol modulators. The Associate Director, Field Reimbursement Lead will manage a team of Field Reimbursement Managers, ensuring effective operations and alignment with national access strategies while addressing complex reimbursement issues.

SVP & Chief Information Security Officer, GSK

Samsung Biologics looks to scale up U.S. manufacturing in Maryland

At-home STD tests offer new options for screening and treatment

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

Abrysvo Or Arexvy Market Competition Analysis 2025: How Players Are Shaping Growth

Associate Director Field Reimbursement, Corporate Accounts

GSK's ViiV Healthcare is a global specialty HIV company focused on delivering new medicines for those living with or at risk of HIV. The Associate Director, Field Reimbursement Corporate Account, will serve as a subject-matter expert on reimbursement and access issues, ensuring appropriate patient access to ViiV's long acting injectables while collaborating with various internal and external stakeholders.

ViiV Healthcare Associate Director Field Reimbursement, Corporate Accounts - Great Lakes

CEO PET Europe

Chief Executive Officer - North America 

Curium Establishes Legal Entity in China

CapVest recapitalises Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Associate Director Field Access and Reimbursement

Curium Pharma is the world’s largest nuclear medicine company, and they are seeking an Associate Director, Field Access and Reimbursement. This remote position focuses on educating healthcare providers about reimbursement processes and ensuring patient access to Curium's products across complex healthcare networks.

Associate Director, Field Reimbursement (great Lakes)

Associate Director, Field Reimbursement (great Lakes) in united states (1000+)